The U.S. had plans to hike duties on at least $250 billion in Chinese goods to 30% from 25% on Tuesday. Despite the partial trade deal, some banks on Sunday wrote that tariff...Marketsread more
Economists polled by Reuters had expected Chinese exports denominated in the U.S. dollar to fall by 3% and imports to decline by 5.2% in September, compared to a year ago.China Economyread more
The industry has pulled in $322 billion over the past six months, the fastest pace since the second half of 2008.Marketsread more
A technical recession occurs when there are two consecutive quarters of economic contraction.Asia Economyread more
"Deepfakes" are being used to depict people in fake videos they did not actually appear in, and can potentially affect elections, diplomacy and how markets move, experts say.Technologyread more
A spokesperson for the U.S.-backed Syrian Democratic Forces (SDF) has issued a stark warning to the international community.World Newsread more
The potential deal would shift Neumann's already diminished voting power to the Japanese conglomerate, according to the Journal.Technologyread more
U.S. President Donald Trump said that both sides reached a "very substantial phase one deal" that will address intellectual property and financial services concerns and...Asia Marketsread more
On Friday, Zedd tweeted about the ban, and CNBC verified the claim with his publicist on Saturday.China Politicsread more
Hunter's vows to forgo any foreign work follow a slew of unsubstantiated attacks by President Donald Trump accusing him of corruption.Politicsread more
Apple, the company that created the modern-day smartphone, is relying on technology customers are already extremely familiar with, like cameras, and taking a backseat when it...Technologyread more
At this time of year Cramer says certain stocks become anointed by Wall Street. That is, select names will attract buyers simply because they've already made big gains.
"Through the end of the year money managers often buy these winners, if only to show clients how smart they are," Cramer explained.
Because Cramer believes these winners will keep on winning due to the mechanics of the money management business, he advocates buying now – ahead of an expected advance.
"And when you look at 2013's best performing health care stocks in the S&P 500 the top pure biotech plays are Celgene, Regeneron, and Gilead," Cramer said.
The phenomenon of window dressing would suggest these stocks should have more room to run. But do they? To either confirm or deny the thesis, Cramer often consults technical analysis. The following technical analysis was provided by Bob Lang, the founder and senior strategist at ExplosiveOptions.net.
Up 87% year to date, patterns in the charts of suggest to Lang it's a buy on a pullback.
Although Celgene has had a bullish run since mid August on high volume, he also notes price action has been weak more recently.
Therefore, Lang suggests waiting until the stock pulls back to its 50-day moving average, which is around $140. As long as Celgene holds above that key moving average, Lang would do some buying in anticipation of a big run into the end of the year.
Read More from Mad Money with Jim Cramer
5 buys as pros puff up protfolios
Cramer: International Paper 'ludicrously' cheap
Cramer's stock with serious upside potential
With gains of 73% year to date, Lang points out that Regeneron stock has not only marched higher it's broken out over a double top on strong volume, hitting a new all-time high. That's very bullish.
However he also notes that both the relative strength index or RSI and the Williams %R oscillator are both in overbought territory. Therefore, Lang suggests waiting for a sell-off before establishing a new position.
Chart patterns suggest to Lang that there should be a floor around $275.
With gains of 70%, Lang says that exhibits one of the best trend-lines in biotech. This stock is advancing almost in straight upward fashion. And he adds the advance has happened on high volume, a sign of conviction that the advance is warranted.
Combine the trend-lines with the phenomenon of window dressing and Lang thinks Gilead can keep roaring.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? email@example.com
Questions, comments, suggestions for the "Mad Money" website? firstname.lastname@example.org